NEW YORK, NEW YORK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account (the “Trust ...

NEW YORK - Denali Capital Acquisition Corp. (NASDAQ: DECA), currently trading at $11.83 with a market capitalization of $39.23 million, has secured an additional month, until January 11, 2025, to ...

NEW YORK - Denali Capital Acquisition Corp. (NASDAQ: DECA), currently trading at $11.83 with a market capitalization of $39.23 million, has secured an additional month, until January 11 ...

NEW YORK, NEW YORK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account ...

Denali Therapeutics Inc. (NASDAQ:DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier for the ...